NAD+ levels fall up to 65% as we age. Learn the clinical science behind Niagen Bioscience's NAD precursor and how it fights ...

As America approaches its 250th anniversary, the companies will pursue the development of scalable seedling technologies to support the first-ever restoration of a native tree species from functional ...

Satellos Bioscience's shares jumped Monday after the Duchenne treatment being developed by the biotechnology company received fast track designation in the U.S. In morning trading, the shares rose 12% ...

South Korea's Penetrium Bioscience said Wednesday that the company would start a clinical test combining its investigational ...

Discover the science of NAD+ and how it impacts your healthspan. Watch Mona Rosene explain cellular repair and how to fight ...

Members of the Albuquerque Regional Economic Alliance and other state organizations will attend the conference June 22-25.

Osterweis Capital Management, an investment management firm, released its Q1 2026 investor update for its “Osterweis ...

SAT-3247 has now received FDA Fast Track, Orphan Drug and Rare Pediatric Disease designations for Duchenne muscular dystrophy ("Duchenne" or "DMD")Fast Track is designed to expedite the development/re ...

Tulane University signed a purchase and sale agreement to transform the abandoned Charity Hospital into a major bioscience ...

The National Vaccine Institute (NVI), the Government Pharmaceutical Organisation (GPO) and the Department of Disease Control ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Regencell Bioscience ...

Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner spanning biology and chemistry.